My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    Tanis: a link between type 2 diabetes and inflammation?

    Walder K, Kantham L, McMillan JS, Trevaskis J, Kerr L, De Silva A, Sunderland T, Godde N, Gao Y, Bishara N, Windmill K, Tenne-Brown J, Augert G, Zimmet PZ, Collier GR.

    Diabetes. 2002 Jun;51(6):1859-66.PMID: 12031974 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Elevation in Tanis expression alters glucose metabolism and insulin sensitivity in H4IIE cells.

    Gao Y, Walder K, Sunderland T, Kantham L, Feng HC, Quick M, Bishara N, de Silva A, Augert G, Tenne-Brown J, Collier GR.

    Diabetes. 2003 Apr;52(4):929-34.PMID: 12663463 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Relationship between serum amyloid A level and Tanis/SelS mRNA expression in skeletal muscle and adipose tissue from healthy and type 2 diabetic subjects.

    Karlsson HK, Tsuchida H, Lake S, Koistinen HA, Krook A.

    Diabetes. 2004 Jun;53(6):1424-8.PMID: 15161744 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Association of SelS mRNA expression in omental adipose tissue with Homa-IR and serum amyloid A in patients with type 2 diabetes mellitus.

    Du JL, Sun CK, Lü B, Men LL, Yao JJ, An LJ, Song GR.

    Chin Med J (Engl). 2008 Jul 5;121(13):1165-8.PMID: 18710632 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications.

    Yang RZ, Lee MJ, Hu H, Pollin TI, Ryan AS, Nicklas BJ, Snitker S, Horenstein RB, Hull K, Goldberg NH, Goldberg AP, Shuldiner AR, Fried SK, Gong DW.

    PLoS Med. 2006 Jun;3(6):e287.PMID: 16737350 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Glucose-regulated proinsulin gene expression is required for adequate insulin production during chronic glucose exposure.

    Leibowitz G, Uçkaya G, Oprescu AI, Cerasi E, Gross DJ, Kaiser N.

    Endocrinology. 2002 Sep;143(9):3214-20.PMID: 12193532 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Serum amyloid A: a marker of adiposity-induced low-grade inflammation but not of metabolic status.

    Poitou C, Coussieu C, Rouault C, Coupaye M, Cancello R, Bedel JF, Gouillon M, Bouillot JL, Oppert JM, Basdevant A, Clément K.

    Obesity (Silver Spring). 2006 Feb;14(2):309-18.PMID: 16571858 [PubMed - indexed for MEDLINE]Related articles

    8.

    The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes.

    Walder K, Kerr-Bayles L, Civitarese A, Jowett J, Curran J, Elliott K, Trevaskis J, Bishara N, Zimmet P, Mandarino L, Ravussin E, Blangero J, Kissebah A, Collier GR.

    Diabetologia. 2005 Mar;48(3):459-68. Epub 2005 Feb 24.PMID: 15729572 [PubMed - indexed for MEDLINE]Related articles

    9.

    Chemerin is a novel adipokine associated with obesity and metabolic syndrome.

    Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K, Segal D.

    Endocrinology. 2007 Oct;148(10):4687-94. Epub 2007 Jul 19.PMID: 17640997 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.

    Hanley AJ, Festa A, D'Agostino RB Jr, Wagenknecht LE, Savage PJ, Tracy RP, Saad MF, Haffner SM.

    Diabetes. 2004 Jul;53(7):1773-81.PMID: 15220201 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Calpain 3 gene expression in skeletal muscle is associated with body fat content and measures of insulin resistance.

    Walder K, McMillan J, Lapsys N, Kriketos A, Trevaskis J, Civitarese A, Southon A, Zimmet P, Collier G.

    Int J Obes Relat Metab Disord. 2002 Apr;26(4):442-9.PMID: 12075569 [PubMed - indexed for MEDLINE]Related articles

    12.

    Acute-phase serum amyloid A as a marker of insulin resistance in mice.

    Scheja L, Heese B, Zitzer H, Michael MD, Siesky AM, Pospisil H, Beisiegel U, Seedorf K.

    Exp Diabetes Res. 2008;2008:230837.PMID: 18584041 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Serum concentrations and expressions of serum amyloid A and leptin in adipose tissue are interrelated: the Genobin Study.

    Lappalainen T, Kolehmainen M, Schwab U, Pulkkinen L, Laaksonen DE, Rauramaa R, Uusitupa M, Gylling H.

    Eur J Endocrinol. 2008 Mar;158(3):333-41.PMID: 18299466 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Channel formation by serum amyloid A: a potential mechanism for amyloid pathogenesis and host defense.

    Hirakura Y, Carreras I, Sipe JD, Kagan BL.

    Amyloid. 2002 Mar;9(1):13-23.PMID: 12000193 [PubMed - indexed for MEDLINE]Related articles

    15.

    Characterization of the unusual insulin of Psammomys obesus, a rodent with nutrition-induced NIDDM-like syndrome.

    Kaiser N, Bailyes EM, Schneider BS, Cerasi E, Steiner DF, Hutton JC, Gross DJ.

    Diabetes. 1997 Jun;46(6):953-7.PMID: 9166665 [PubMed - indexed for MEDLINE]Related articles

    16.

    Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes.

    McTernan PG, Fisher FM, Valsamakis G, Chetty R, Harte A, McTernan CL, Clark PM, Smith SA, Barnett AH, Kumar S.

    J Clin Endocrinol Metab. 2003 Dec;88(12):6098-106.PMID: 14671216 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes.

    Fraenkel M, Ketzinel-Gilad M, Ariav Y, Pappo O, Karaca M, Castel J, Berthault MF, Magnan C, Cerasi E, Kaiser N, Leibowitz G.

    Diabetes. 2008 Apr;57(4):945-57. Epub 2008 Jan 3.PMID: 18174523 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogue.

    Uçkaya G, Delagrange P, Chavanieu A, Grassy G, Berthault MF, Ktorza A, Cerasi E, Leibowitz G, Kaiser N.

    J Endocrinol. 2005 Mar;184(3):505-13.PMID: 15749809 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment.

    Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS.

    Diabetes. 2002 Jun;51(6):1913-20.PMID: 12031981 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population.

    Helmersson J, Vessby B, Larsson A, Basu S.

    Circulation. 2004 Apr 13;109(14):1729-34. Epub 2004 Mar 22.PMID: 15037525 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity